Organovo Holdings

organovo.com

Organovo Holdings is pioneering the development of 3D human tissues for drug discovery and regenerative medicine. Their innovative technology allows for the creation of tissue on demand, addressing unmet medical needs across various applications. With a focus on delivering breakthrough capabilities, Organovo is positioned as a leader in the field, leveraging their unique approach to tissue engineering to enhance research and surgical outcomes. The company is actively involved in clinical trials and has demonstrated strong preclinical and human rationale for their products, indicating significant traction in the market.